{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:38:14Z","timestamp":1790948294498,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA013520"],"award-info":[{"award-number":["U01 AA013520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuropharm.2022.109255","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:56:55Z","timestamp":1663765015000},"page":"109255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA \u03b23 subunits"],"prefix":"10.1016","volume":"220","author":[{"given":"Yuri A.","family":"Blednov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109255_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2014.00129","article-title":"Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL\/6J mice","volume":"8","author":"Blednov","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108220","article-title":"Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling","volume":"178","author":"Blednov","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109255_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/acer.13615","article-title":"Apremilast alters behavioral responses to ethanol in mice: II. Increased sedation, intoxication, and reduced acute functional tolerance","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109255_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/acer.13616","article-title":"Apremilast alters behavioral responses to ethanol in mice: I. Reduced consumption and preference","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109255_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1601-183X.2012.00780.x","article-title":"Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data","volume":"11","author":"Blednov","year":"2012","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2022.109255_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2016.01.009","article-title":"Differential regulation of synaptic and extrasynaptic alpha4 GABA(A) receptor populations by protein kinase A and protein kinase C in cultured cortical neurons","volume":"105","author":"Bohnsack","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109255_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fnmol.2018.00154","article-title":"PKA and PKC modulators affect ion channel function and internalization of recombinant alpha1 and alpha1-beta glycine receptors","volume":"11","author":"Breitinger","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.115.228056","article-title":"Regulation of extrasynaptic GABAA alpha4 receptors by ethanol-induced protein kinase A, but not protein kinase C activation in cultured rat cerebral cortical neurons","volume":"356","author":"Carlson","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109255_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/mp.2017.153","article-title":"Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117)","volume":"22","author":"Clarke","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109255_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10519-006-9067-6","article-title":"Effects of genetic and procedural variation on measurement of alcohol sensitivity in mouse inbred strains","volume":"36","author":"Crabbe","year":"2006","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2022.109255_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0022-3565(25)21291-5","article-title":"Genetic selection and characterization of mouse lines for acute functional tolerance to ethanol","volume":"279","author":"Erwin","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109255_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2022.109255_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00213-014-3852-3","article-title":"Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4)","volume":"232","author":"Franklin","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109255_bib14","article-title":"The FDA-approved drug apremilast suppresses alcohol intake: clinical and pre-clinical validation","volume":"2021","author":"Grigsby","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2022.109255_bib15","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00213-014-3480-y","article-title":"Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior","volume":"231","author":"Hansen","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109255_bib16","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/bi00316a032","article-title":"Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C","volume":"23","author":"Hidaka","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2022.109255_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-011-2290-8","article-title":"Inhibition of phosphodiesterase-4 decreases ethanol intake in mice","volume":"218","author":"Hu","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109255_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/jpet.108.137521","article-title":"Genomic insights into acute alcohol tolerance","volume":"326","author":"Hu","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109255_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archgenpsychiatry.2011.26","article-title":"Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking","volume":"68","author":"King","year":"2011","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109255_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnins.2012.00044","article-title":"Ethanol activation of protein kinase A regulates GABA(A) receptor subunit expression in the cerebral cortex and contributes to ethanol-induced hypnosis","volume":"6","author":"Kumar","year":"2012","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1196\/annals.1441.022","article-title":"Protein kinases and addiction","volume":"1141","author":"Lee","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib22","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41598-019-39116-2","article-title":"Phosphorylation changes in response to kinase inhibitor H89 in PKA-null cells","volume":"9","author":"Limbutara","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109255_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"Liu","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2022.109255_bib24","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00213-017-4631-8","article-title":"The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL\/6J mice","volume":"234","author":"Liu","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109255_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1527-3466.2006.00261.x","article-title":"The many faces of H89: a review","volume":"24","author":"Lochner","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.neuropharm.2022.109255_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.alcohol.2015.03.007","article-title":"Phosphodiesterase regulation of alcohol drinking in rodents","volume":"49","author":"Logrip","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2022.109255_bib27","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1523\/JNEUROSCI.0154-16.2016","article-title":"Ethanol-induced motor impairment mediated by inhibition of alpha7 nicotinic receptors","volume":"36","author":"McDaid","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/223","article-title":"Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase","volume":"1","author":"McDonald","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1530-0277.2010.01383.x","article-title":"Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL\/6J mice","volume":"35","author":"Melendez","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109255_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes6040042","article-title":"Evaluation of the phosphoproteome of mouse alpha 4\/beta 2-containing nicotinic acetylcholine receptors in vitro and in vivo","volume":"6","author":"Miller","year":"2018","journal-title":"Proteomes"},{"key":"10.1016\/j.neuropharm.2022.109255_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1323140","article-title":"Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation","volume":"257","author":"Moss","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109255_bib32","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1074\/jbc.RA120.014303","article-title":"Phosphorylation on Ser-359 of the alpha2 subunit in GABA type A receptors down-regulates their density at inhibitory synapses","volume":"295","author":"Nakamura","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109255_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2005.07.004","article-title":"Intracellular signaling pathways that regulate behavioral responses to ethanol","volume":"109","author":"Newton","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109255_bib34","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","article-title":"PDE4 as a target for cognition enhancement","volume":"17","author":"Richter","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2022.109255_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1369-1600.2012.00481.x","article-title":"Escalation of intake under intermittent ethanol access in diverse mouse genotypes","volume":"18","author":"Rosenwasser","year":"2013","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2022.109255_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrn1496","article-title":"Molecular and neuronal substrates for general anaesthetics","volume":"5","author":"Rudolph","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109255_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neulet.2007.02.024","article-title":"Etomidate and propofol-hyposensitive GABAA receptor beta3(N265M) mice show little changes in acute alcohol sensitivity but enhanced tolerance and withdrawal","volume":"416","author":"Sanchis-Segura","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109255_bib38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2022.109255_bib39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109255_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajmg.b.10022","article-title":"Association of GABA(A) receptors and alcohol dependence and the effects of genetic imprinting","volume":"117B","author":"Song","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.neuropharm.2022.109255_bib41","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1073\/pnas.1514657112","article-title":"Compromising the phosphodependent regulation of the GABAAR beta3 subunit reproduces the core phenotypes of autism spectrum disorders","volume":"112","author":"Vien","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109255_bib42","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00213-018-4895-7","article-title":"Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder","volume":"235","author":"Wen","year":"2018","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109255_bib43","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1530-0277.2012.01845.x","article-title":"The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats","volume":"36","author":"Wen","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2022.109255_bib44","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109255_bib45","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","article-title":"Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109255_bib46","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1021\/acs.jmedchem.7b01050","article-title":"The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109255_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41593-020-0643-5","article-title":"Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits","volume":"23","author":"Zhou","year":"2020","journal-title":"Nat. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:20:34Z","timestamp":1758439234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":47,"alternative-id":["S0028390822003148"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109255","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA \u03b23 subunits","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109255"}}